Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 13, 2013 - Issue 10
Submit an article Journal homepage
514
Views
6
CrossRef citations to date
0
Altmetric
Editorial

New insights into drug development for pediatric solid tumors: what preclinical data justify clinical trials in pediatric cancer?

Peter J HoughtonCenter for Childhood Cancer, The Research Institute, Nationwide Children’s Hospital, 700 Children’s Drive, Columbus, OH 43205, USA+1 614 355 2670+1 614 355 [email protected]
Pages 1135-1138 | Published online: 10 Jan 2014

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Steffen Hirsch, Lynley V Marshall, Fernando Carceller Lechon, Andrew DJ Pearson & Lucas Moreno. (2015) Targeted approaches to childhood cancer: progress in drug discovery and development. Expert Opinion on Drug Discovery 10:5, pages 483-495.
Read now

Articles from other publishers (5)

Paula Valle-Simón, Alberto M. Borobia & Antonio Pérez-Martínez. (2023) Clinical research with targeted drugs in paediatric oncology. Drug Discovery Today 28:8, pages 103672.
Crossref
Elly Barry, Jaimie A. Walsh, Scott L. Weinrich, Darrin Beaupre, Eileen Blasi, Daniel R. Arenson & Ira A. Jacobs. (2021) Navigating the Regulatory Landscape to Develop Pediatric Oncology Drugs: Expert Opinion Recommendations. Pediatric Drugs 23:4, pages 381-394.
Crossref
James Snyder, Laila M Poisson, Houtan Noushmehr, Ana V Castro, Ana C deCarvalho, Adam Robin, Abir Mukherjee, Ian Lee & Tobias Walbert. (2019) Clinical and research applications of a brain tumor tissue bank in the age of precision medicine. Personalized Medicine 16:2, pages 145-156.
Crossref
Monika Lavan, Stephen R. Byrn & Gregory Knipp. (2019) Pediatric Formulations: Knowledge Gaps Limiting the Expedited Preclinical to Clinical Translation in Children. AAPS PharmSciTech 20:2.
Crossref
L Jones, H Carol, K Evans, J Richmond, P J Houghton, M A Smith & R B Lock. (2016) A review of new agents evaluated against pediatric acute lymphoblastic leukemia by the Pediatric Preclinical Testing Program. Leukemia 30:11, pages 2133-2141.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.